Skip to content
Trial Eligibility
Menu

Lupus Clinical Trials near Houston, TX

17 studies for Lupus are recruiting at 27 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lupus trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lupus studies enrolling near Houston

Showing 17 studies, nearest first.
  1. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    NCT06617325

    • Phase 3
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Sl0044 50696 (Houston, TX); Sl0044 50723 (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  2. A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

    NCT07201129

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Northwest Houston Arthritis (Houston, TX); Novel Research, LLC. (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    NCT07430306

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Research Site (Houston, TX); Research Site (Sugar Land, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

    NCT06434363

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); The University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

    NCT07611214

    • Phase 4
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Northwest Houston Arthritis Center (Houston, TX); Novel Research LLC (Bellaire, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

    NCT04751396

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

    NCT05538208

    • Phase 2
    • Ages 8 to 20 years
    • Sex: All

    Nearest site: Baylor College of Medicine Pediatric Immunology Allergy Rheumatology (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    NCT05835310

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: Research Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    NCT06121297

    • Phase 1/2
    • Ages 12 to 65 years
    • Sex: All

    Nearest site: University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    NCT06557265

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Nkarta Investigational Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

    NCT06975787

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    NCT06133972

    • Phase 3
    • Ages 12 to 100 years
    • Sex: All

    Nearest sites: Novel Research LLC (Bellaire, TX); Accurate Clinical Research (League City, TX)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

    NCT07355218

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Accurate Clinical Research (Humble, TX)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

    NCT07438496

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Fort Bend Rheumatology Associates PLLC (Sugar Land, TX); R and H Clinical Research (Katy, TX)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

    NCT06613360

    • Phase 1
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Tranquil Clinical Research (Webster, TX)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

    NCT07409181

    • Phase 2
    • Ages 18 to 74 years
    • Sex: All

    Nearest site: R&H Clinical Research - Katy (Katy, TX)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lupus clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.